Eastern AHSN has published its latest impact review which celebrates its impact for the last financial year, told largely through the stories of the people it has worked with.

This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors, was published in Drug Metabolism and Disposition (DMD)

QxMD Builds on Medscape’s Point-of-Care Tools and Services

New York, NY, August 12, 2019: WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, has acquired QxMD, a Vancouver, BC-based learning technology company that delivers mobile decision point tools and personalized learning solutions for physicians and health care professionals (HCPs).

Research Triangle Park, N.C. (Aug. 13, 2019) – AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression. Synpromics will operate as a wholly owned subsidiary and remain headquartered in Edinburgh, United Kingdom.

Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.

Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing Centre (“CGTCMC”). Kadans will redevelop and extend Sycamore House into a modern, vibrant, multi-tenanted R&D facility with expected completion mid-2021.

CAMBRIDGE, UK, 09 August 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with Clustermarket, a leading online equipment sharing and booking platform and Science Entrepreneur Club, a life sciences network, to help drive the translation of world-class life science and healthcare research into commercially successful companies.

Click here for the latest edition of eNews. 

This transaction increases BioIVT’s portfolio of disease-state plasma, sera and controls, and enhances its ability to support the in vitro diagnostic market

Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.

This Transaction Increases BioIVT’s Portfolio of Disease-State Plasma, Sera and Controls, and Enhances its Ability to Support the In Vitro Diagnostic Market


Cambridge, UK, 6th August 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, welcomed Mrs Kemi Badenoch, MP for Saffron Walden, to its offices at Chesterford Research Park.

Arecor’s Chief Executive Officer, Dr Sarah Howell and Chief Financial Officer, Susan Lowther, met with Mrs Badenoch MP, to discuss the current climate for small companies in the UK healthcare industry.